|
|
|
|
Partial List of Publications Kenneth B Klein, MD
 Note: For publications listed in color, clicking on the citation will provide the entire text in Adobe Acrobat PDF format
|
Original Articles
|
| 1. |
Klein K, Stenzel P, Katon RM. Pouch ileitis: report of a case with severe systemic manifestations. J Clin Gastroenterol. 1983;5:149-153.
|
|
|
| 2. |
Gurian L, Klein K, Ward TT Role of Clostridium difficile and Campylobacter jejuni in relapses of inflammatory bowel disease. West J Med. 1983;138:359-360.
|
|
|
| 3. |
Ward TT, Klein K, Borthistle BK Jejunal infection with Campylobacter. Arch Intern Med. 1984;144:1072-1074.
|
|
|
| 4. |
Klein KB. Drug therapy in the irritable bowel syndrome. Practical Gastroenterology. 1986;10:8-14.
|
|
|
| 5. |
Klein KB Irritable bowel syndrome: Rational use of drugs. Drug Therapy. 1987;17(8):17-32.
|
|
|
| 6. |
Klein KB, Orwoll ES, Lieberman DA Meier DE, McClung MR, Parfitt AM. Metabolic bone disease in asymptomatic men after partial gastrectomy with Billroth II anastomosis. Gastroenterology. 1987;92:608-616.
|
|
|
| 7. |
Klein KB Controlled treatment trials in the irritable bowel syndrome: a critique. Gastroenterology. 1988;95:232-241.
|
|
|
| 8. |
Klein KB Treatment of the irritable bowel syndrome. Drugs of Today. 1988;24:589-595.
|
|
|
| 9. |
Klein K, Fuchs GJ, Kulapongs P, Mertz G, Suskind RM, Olson RE. Endotoxemia in protein-energy malnutrition. J Pediatr Gastroenterol Nutr. 1988;7:225-228.
|
|
|
| 10. |
Klein KB, Spiegel D. Modulation of gastric acid secretion by hypnosis. Gastroenterology. 1989;96:1383-1387.
|
|
|
| 11. |
Balasubramanian R, Klein KB, Pittman AW, Liao SH, Findlay JWA, Frosolono MF. Pharmacokinetics of acrivastine after oral and colonic administration. J Clin Pharmacol. 1989;29:444-447.
|
|
|
| 12. |
Klein KB Chronic intractable abdominal pain. Sem Gastrointest Dis. 1990;1:43-56.
|
|
|
| 13. |
Klein KB. Biliary tract disease and pancreatitis in pregnancy. Practical Gastroenterology. 1991;15(#2):46-51.
|
|
|
| 14. |
Visser WH, Klein KB, Cox R, Jones D, Ferrari MD 311C90, a new central and peripherally acting 5-HT1D receptor agonist in the acute oral treatment of migraine: a double blind, placebo controlled dose range finding study. Neurology. 1996:46:522-526.
|
|
|
| 15. |
Ferrari MD, Martin GR, Earl NL, Klein KB. Emerging preclinical and clinical profile of 311C90: A poster review and discussion. Eur Neurol. 1996:36(suppl 2):19-23.
|
|
|
| 16. |
Dahlof C, Diener HC, Goadsby PJ, Massiou H, Olesen J, Schoenen J, Wilkinson M, Sweet RM, Klein KB Zolmitriptan, a 5-HT1B/1D receptor agonist for the acute oral treatment of migraine: a multicentre, dose-range finding study Eur J Neurol. 1998;5:535-543.
|
|
|
| 17. |
van Zanten SJ, Talley NJ, Bytzer P, Klein KB, Whorwell PJ, Zinsmeister AR Design of treatment trials for functional gastrointestinal disorders. Gut. 1999;45 Suppl 2:II69-II77.
|
|
|
| 18. |
Paterson WG, Thompson WG, Vanner SJ, et al. Recommendations for the management of irritable bowel syndrome in family practice. JAMC. 1999;161:154-160.
|
|
|
|
|
 |
Copyright © 2001-2008 Kenneth Klein, MD All Rights Reserved
|
|
|
